Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients
NCT00000238Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Aug 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Started Aug 1997; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000238.